TELO (Telomir Pharmaceuticals) Machinery, Furniture, Equipment : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Telomir Pharmaceuticals Machinery, Furniture, Equipment?

Telomir Pharmaceuticals's Machinery, Furniture, Equipment for the quarter that ended in Sep. 2024 was $0.00 Mil.

Telomir Pharmaceuticals Machinery, Furniture, Equipment Historical Data

The historical data trend for Telomir Pharmaceuticals's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telomir Pharmaceuticals Machinery, Furniture, Equipment Chart

Telomir Pharmaceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Machinery, Furniture, Equipment

Telomir Pharmaceuticals Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Machinery, Furniture, Equipment	Get a 7-Day Free Trial						-	-	-	-	-

Telomir Pharmaceuticals Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Telomir Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telomir Pharmaceuticals Inc (NAS:TELO) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

855 N Wolfe Street, Suite 601, Baltimore, MD, USA, 21205

Website

https://www.telomirpharma.com

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.